“ANTI-GAD AND C-PEPTIDE IN EARLY-ONSET NON-OVERWEIGHT PATIENTS WITH TYPE 2 DIABETES: IMPLICATIONS FOR LADA SCREENING”, YHCĐ, vol. 67, no. CĐ11-NCKH, July 2026, doi: 10.52163/yhc.v67iCD11.6038.